Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gevers

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|June 18, 2019
Estrogen-Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal PatientsRené M M van Aerts, Lucas H P Bernts, Tom J G Gevers, et al.
BMC Nephrology|May 27, 2017
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regressionMyrte K Neijenhuis, Wietske Kievit, Ronald D Perrone, et al.
AJR. American Journal of Roentgenology|November 9, 2016
Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic ReviewTitus F M Wijnands, Alena P M Görtjes, Tom J G Gevers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2023
Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022Romée J A L M Snijders, David N Assis, Ye H Oo, et al.
Clinics and Research in Hepatology and Gastroenterology|June 16, 2026
Dipstick urinary chloride as a surrogate marker of urinary sodium in cirrhosis: a prospective multicenter pilot studySusan E Fischer, Britt van Ruijven, Annarein J C Kerbert, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2011
The long-term outcome of patients with polycystic liver disease treated with lanreotideM Chrispijn, F Nevens, T J G Gevers, et al.
Hepatology (Baltimore, Md.)|March 13, 2016
Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver DiseaseMyrte K Neijenhuis, Tom J G Gevers, Marie C Hogan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 12, 2025
Liver transplantation indications and strategies in polycystic liver disease: A european surveyRenée Duijzer, Ian P J Alwayn, Flaminia Ferri, et al.
International Journal of Cardiology|April 4, 2025
Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensationMax F G H M Venner, Tom J G Gevers, Fabienne Ploum, et al.
BMC Health Services Research|May 10, 2025
What do patients and informal caregivers value in IBD care? A narrative inquiryBritt J M Thomassen, Evelien M B Hendrix, Zlatan Mujagic, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|June 18, 2019
Estrogen-Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal PatientsRené M M van Aerts, Lucas H P Bernts, Tom J G Gevers, et al.
BMC Nephrology|May 27, 2017
The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regressionMyrte K Neijenhuis, Wietske Kievit, Ronald D Perrone, et al.
AJR. American Journal of Roentgenology|November 9, 2016
Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic ReviewTitus F M Wijnands, Alena P M Görtjes, Tom J G Gevers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2023
Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022Romée J A L M Snijders, David N Assis, Ye H Oo, et al.
Clinics and Research in Hepatology and Gastroenterology|June 16, 2026
Dipstick urinary chloride as a surrogate marker of urinary sodium in cirrhosis: a prospective multicenter pilot studySusan E Fischer, Britt van Ruijven, Annarein J C Kerbert, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2011
The long-term outcome of patients with polycystic liver disease treated with lanreotideM Chrispijn, F Nevens, T J G Gevers, et al.
Hepatology (Baltimore, Md.)|March 13, 2016
Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver DiseaseMyrte K Neijenhuis, Tom J G Gevers, Marie C Hogan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 12, 2025
Liver transplantation indications and strategies in polycystic liver disease: A european surveyRenée Duijzer, Ian P J Alwayn, Flaminia Ferri, et al.
International Journal of Cardiology|April 4, 2025
Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensationMax F G H M Venner, Tom J G Gevers, Fabienne Ploum, et al.
BMC Health Services Research|May 10, 2025
What do patients and informal caregivers value in IBD care? A narrative inquiryBritt J M Thomassen, Evelien M B Hendrix, Zlatan Mujagic, et al.
Pageof 10